Metabolic Dysfunction and Altered Mitochondrial Dynamics in the Utrophin-Dystrophin Deficient Mouse Model of Duchenne Muscular Dystrophy

por Pant, Meghna, Sopariwala, Danesh H., Bal, Naresh C., Lowe, Jeovanna, Delfín, Dawn A., Rafael-Fortney, Jill, Periasamy, Muthu
Publicado 2015

Mineralocorticoid receptor antagonists and glucocorticoids differentially affect skeletal muscle inflammation and pathology in muscular dystrophy

por Howard, Zachary M., Gomatam, Chetan K., Rabolli, Charles P., Lowe, Jeovanna, Piepho, Arden B., Bansal, Shyam S., Accornero, Federica, Rafael-Fortney, Jill A.
Publicado 2022

Muscle Twitch Kinetics Are Dependent on Muscle Group, Disease State, and Age in Duchenne Muscular Dystrophy Mouse Models

por Peczkowski, Kyra K., Rastogi, Neha, Lowe, Jeovanna, Floyd, Kyle T., Schultz, Eric J., Karaze, Tallib, Davis, Jonathan P., Rafael-Fortney, Jill A., Janssen, Paul M. L.
Publicado 2020

Corrigendum: Muscle Twitch Kinetics Are Dependent on Muscle Group, Disease State, and Age in Duchenne Muscular Dystrophy Mouse Models

por Peczkowski, Kyra K., Rastogi, Neha, Lowe, Jeovanna, Floyd, Kyle T., Schultz, Eric J., Karaze, Tallib, Davis, Jonathan P., Rafael-Fortney, Jill A., Janssen, Paul M. L.
Publicado 2022

Micro-dystrophin gene therapy prevents heart failure in an improved Duchenne muscular dystrophy cardiomyopathy mouse model

por Howard, Zachary M., Dorn, Lisa E., Lowe, Jeovanna, Gertzen, Megan D., Ciccone, Pierce, Rastogi, Neha, Odom, Guy L., Accornero, Federica, Chamberlain, Jeffrey S., Rafael-Fortney, Jill A.
Publicado 2021

The Angiotensin Converting Enzyme Inhibitor Lisinopril Improves Muscle Histopathology but not Contractile Function in a Mouse Model of Duchenne Muscular Dystrophy

por Lowe, Jeovanna, Wodarcyk, Andrew J., Floyd, Kyle T., Rastogi, Neha, Schultz, Eric J., Swager, Sarah A., Chadwick, Jessica A., Tran, Tam, Raman, Subha V., Janssen, Paul M.L., Rafael-Fortney, Jill A.
Publicado 2015

Mineralocorticoid Receptor Signaling Contributes to Normal Muscle Repair After Acute Injury

por Hauck, J. Spencer, Howard, Zachary M., Lowe, Jeovanna, Rastogi, Neha, Pico, Madison G., Swager, Sarah A., Petrosino, Jennifer M., Gomez-Sanchez, Celso E., Gomez-Sanchez, Elise P., Accornero, Federica, Rafael-Fortney, Jill A.
Publicado 2019

Micro-dystrophin gene therapy demonstrates long-term cardiac efficacy in a severe Duchenne muscular dystrophy model

por Piepho, Arden B., Lowe, Jeovanna, Cumby, Laurel R., Dorn, Lisa E., Lake, Dana M., Rastogi, Neha, Gertzen, Megan D., Sturgill, Sarah L., Odom, Guy L., Ziolo, Mark T., Accornero, Federica, Chamberlain, Jeffrey S., Rafael-Fortney, Jill A.
Publicado 2023

Mineralocorticoid receptor antagonism by finerenone is sufficient to improve function in preclinical muscular dystrophy

por Lowe, Jeovanna, Kolkhof, Peter, Haupt, Michael J., Peczkowski, Kyra K., Rastogi, Neha, Hauck, J. Spencer, Kadakia, Feni K., Zins, Jonathan G., Ciccone, Pierce C., Smart, Suzanne, Sandner, Peter, Raman, Subha V., Janssen, Paul M.L., Rafael‐Fortney, Jill A.
Publicado 2020